Video Experimental Relacionado

Updated: Feb 4, 2026

A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep

A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep

Published on: July 15, 2021

Progreso anual en rehabilitación pulmonar en 2025

Y S Chen¹, H Y Jiang², Z H Tong³

¹Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

|February 2, 2026

Resumen

La investigación en rehabilitación pulmonar (RP) muestra avances en accesibilidad y espectro de enfermedades. Los programas simplificados y los cursos más cortos mejoran la eficacia y el alcance, haciendo que la RP sea más precisa y universalmente disponible.

Área de la Ciencia:

Medicina Pulmonar; Ciencia de la Rehabilitación; Investigación de Servicios de Salud

Sus antecedentes:

La cobertura de rehabilitación pulmonar (RP) es subóptima a nivel mundial, marcada por disparidades socioeconómicas, problemas de calidad y baja adherencia.
La investigación actual en RP se centra en la implementación, la expansión del espectro de enfermedades, la innovación conceptual y los avances tecnológicos.

Objetivo del estudio:

Resumir los principales avances en la investigación de rehabilitación pulmonar de octubre de 2024 a septiembre de 2025.
Destacar los desarrollos clave en la implementación de la RP, el espectro de enfermedades, los conceptos innovadores y la tecnología.

Principales métodos:

Revisión bibliográfica exhaustiva de la investigación reciente en rehabilitación pulmonar.
Análisis de estudios centrados en la implementación de la RP, el espectro de enfermedades, los cambios conceptuales y la integración tecnológica.

Principales resultados:

Los equipos simplificados de RP y los cursos más cortos mejoran la accesibilidad y mantienen la eficacia.
La RP se está expandiendo más allá de las enfermedades respiratorias crónicas para incluir comorbilidades y prevención temprana.
La telerrehabilitación ofrece un alcance más amplio, pero los programas basados en centros conservan ventajas únicas.
La integración tecnológica, incluidos los sistemas digitales y las nuevas modalidades de entrenamiento, enriquece las estrategias de RP.

Conclusiones:

La rehabilitación pulmonar está evolucionando hacia un modelo de atención integrada más preciso, continuo y accesible.
Abordar las disparidades socioeconómicas y mejorar la calidad del programa son cruciales para un acceso equitativo a la RP.
La integración de la tecnología y la aplicación ampliada de la RP son direcciones futuras clave.

Palabras clave:

rehabilitación pulmonar avances accesibilidad atención respiratoria innovación tecnológica

Más Videos Relacionados

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Videos de Conceptos Relacionados

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.